Citation Impact
Citing Papers
Developmental Exposure to Estradiol and Bisphenol A Increases Susceptibility to Prostate Carcinogenesis and Epigenetically Regulates Phosphodiesterase Type 4 Variant 4
2006
Regression Shrinkage and Selection Via the Lasso
1996 Standout
Autonomic Nerve Development Contributes to Prostate Cancer Progression
2013 StandoutScience
Targeted cell killing by reconstituted caspases
2007 StandoutNobel
Epigenetic regulation of hypoxic sensing disrupts cardiorespiratory homeostasis
2012 StandoutNobel
Prostate Stroma: Physiology
1999
Naturally occurring and induced neuronal death in the chick embryo in vivo requires protein and RNA synthesis: Evidence for the role of cell death genes
1990
Control of type-D GABAergic neuron differentiation by C. elegans UNC-30 homeodomain protein
1994 StandoutNatureNobel
Mesoporous silica nanoparticles in biomedical applications
2012 StandoutNobel
Synthesis of Biomolecule‐Modified Mesoporous Silica Nanoparticles for Targeted Hydrophobic Drug Delivery to Cancer Cells
2011 StandoutNobel
Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE
1994 StandoutNature
The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme
1993 Standout
IL3-Dependent Cells Die by Apoptosis on Removal of their Growth Factor
1991
The C. elegans Cell Corpse Engulfment Gene ced-7 Encodes a Protein Similar to ABC Transporters
1998 StandoutNobel
The generation of diversity and pattern in animal development
1992 StandoutNobel
Mechanisms and Functions of Cell Death
1991 Standout
An Alternatively Spliced C. elegans ced-4 RNA Encodes a Novel Cell Death Inhibitor
1996 StandoutNobel
PREVENTION OF URINARY TRACT INFECTION
1997
Persistent and transcriptionally-dependent increase in protein phosphorylation in long-term facilitation ofAplysia sensory neurons
1989 StandoutNatureNobel
DIAGNOSIS AND TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION
1997 Standout
Lethal effect of the anti-Fas antibody in mice
1993 StandoutNature
Papillomaviruses and cancer: from basic studies to clinical application
2002 StandoutNobel
The C. elegans Protein EGL-1 Is Required for Programmed Cell Death and Interacts with the Bcl-2–like Protein CED-9
1998 StandoutNobel
Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade
1997 Standout
Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis
1995 StandoutNature
Caenorhabditis elegans CED-9 protein is a bifunctional cell-death inhibitor
1997 StandoutNatureNobel
The Fas Death Factor
1995 StandoutScience
Cholinergic innervation and function in the prostate gland
2002
Inhibition of Carnitine Palmitoyltransferase I Augments Sphingolipid Synthesis and Palmitate-induced Apoptosis
1997 StandoutNobel
De novo reconstitution of a functional mammalian urinary bladder by tissue engineering
1999
The TRA-1A Sex Determination Protein of C. elegans Regulates Sexually Dimorphic Cell Deaths by Repressing the egl-1 Cell Death Activator Gene
1999 StandoutNobel
Octreotide in the Management of Hormone-Refractory Prostate Cancer
2001
C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2
1994 StandoutNobel
Activation of C. elegans cell death protein CED-9 by an ammo-acid substitution in a domain conserved in Bcl-2
1994 StandoutNatureNobel
Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein
1995 StandoutNatureNobel
C. elegans phagocytosis and cell-migration protein CED-5 is similar to human DOCK180
1998 StandoutNatureNobel
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
1987 Standout
An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair.
1993 StandoutNobel
SPAS-1 (stimulator of prostatic adenocarcinoma-specific T cells)/SH3GLB2: A prostate tumor antigen identified by CTLA-4 blockade
2008 StandoutNobel
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
1995 StandoutScience
Exploiting Differences in Sialoside Expression for Selective Targeting of MRI Contrast Reagents
1999 StandoutNobel
Memory--a Century of Consolidation
2000 StandoutScience
Apoptosis in the Pathogenesis and Treatment of Disease
1995 StandoutScience
Prevention of Apoptosis by Bcl-2: Release of Cytochrome c from Mitochondria Blocked
1997 StandoutScience
MOD-1 is a serotonin-gated chloride channel that modulates locomotory behaviour in C. elegans
2000 StandoutNatureNobel
Cyclin B2-null mice develop normally and are fertile whereas cyclin B1-null mice die in utero
1998 StandoutNobel
Tissue-engineered autologous bladders for patients needing cystoplasty
2006 Standout
Developing Caenorhabditis elegans neurons may contain both cell-death protective and killer activities.
1996 StandoutNobel
Tissue Engineering--Current Challenges and Expanding Opportunities
2002 StandoutScience
The Caenorhabditis elegans mucolipin-like gene cup-5 is essential for viability and regulates lysosomes in multiple cell types
2002 StandoutNobel
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
1993 Standout
Up-regulation of the oligosaccharide sialyl LewisX: a new prognostic parameter in metastatic prostate cancer.
1995
Molecular cloning of a complementary DNA encoding a prostate-specific membrane antigen.
1993
Genetically targeted cell disruption in Caenorhabditis elegans
1997 StandoutNobel
Two-dimensional gel electrophoresis of proteins
1987
Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radical Prostatectomy Treated Patients
1989
Human Papillomaviruses and Their Possible Role in Squamous Cell Carcinomas
1977 StandoutNobel
Induction and Evasion of Host Defenses by Type 1-Piliated Uropathogenic Escherichia coli
1998 StandoutScience
A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions.
1983 StandoutNobel
Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers.
1983 StandoutNobel
Translocation of C. elegans CED-4 to Nuclear Membranes During Programmed Cell Death
2000 StandoutScienceNobel
Evaluation of prostate-specific antigen and prosttic acid phosphatase as prostate cancer markers
1986
Nerve growth factor withdrawal-induced cell death in neuronal PC12 cells resembles that in sympathetic neurons.
1992
Caspases: Enemies Within
1998 StandoutScience
Programmed cell death and Bcl-2 protection in the absence of a nucleus.
1994
Mechanisms and Genes of Cellular Suicide
1995 StandoutScience
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
1999 StandoutNobel
The Caenorhabditis elegans cell death gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death
1992 StandoutNobel
Works of John T. Grayhack being referenced
Partial inhibition of castration induced ventral prostate regression with actinomycin D and cycloheximide.
1978
Epidermal growth factor-related peptides in human prostatic fluid: Sources of variability in assay results
1997
Endocrine Therapy in the Management of Advanced Prostatic Cancer: The Case for Early Initiation of Treatment
1980
Buschke-Loewenstein Tumor of the Penis
1967
Effect of Estradiol on the Rat Prostate in the Presence and Absence of Testosterone and Pituitary
1981
THE PATHOGENESIS OF BENIGN PROSTATIC HYPERPLASIA: A PROPOSED HYPOTHESIS AND CRITICAL EVALUATION
1998
Acid Phosphatase
1979
Systematic characterization of human prostatic fluid proteins with two-dimensional electrophoresis.
1984
Prostatic Carcinoma: Management
1984
Elevated Transferrin Receptor Content in Human Prostate Cancer Cell Lines Assessed in Vitro and in Vivo
1990
The Role of Excretory Urography and Cystoscopy in the Evaluation and Management of Women with Recurrent Urinary Tract Infection
1980
Reversed Seromuscular Flaps in the Urinary Tract in Dogs
1994
Carcinoma of the prostate. Hormonal therapy
1987
Prognostic significance of tumor grade and stage in the patient with carcinoma of the prostate
1983